Skip to content

Public FDA record

Z-1352-2018: Magstim Rapid Therapy System consisting of: Rapid Mainframe, Rapid Single Power Supply Unit , Rapid User

Recall record Z-1352-2018 for The Magstim Company Limited. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1352-2018
Company in FDA record
The Magstim Company Limited
FDA record creation date
Apr 11, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Users manuals not supplied with 4800-00T US Rapid Therapy System

Source facts

Action
On September 28, 2017 the recalling firm sent a Field Safety Notice that included the Operating Manual to all their customers involved in this event. An Acknowledgement card was attached to the letter to be sent back to the recalling firm informing that they received the Operating Manual
Initiated
2017-09-28
Root cause
Employee error
Terminated
2022-06-21
Distribution
US Nationwide Distribution in the states of AR, CA, GA, KS, MA, MD, MO, NC, NJ, NW, NY, TX and Hawaii
Recall number
Z-1352-2018
Recall status
Terminated
CDRH record ID
162681
FDA record created
2018-04-11
Recall event number
79577

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗